TY - JOUR T1 - Seroprevalence of Varicella Zoster virus in China: an age-stratifed systematic review and meta-analysis JF - medRxiv DO - 10.1101/19009449 SP - 19009449 AU - Li Wang AU - Fu Sun AU - Siyang Liu AU - Hongyi Zhang AU - Bo Lu AU - Xiaoli Shao AU - Minxin Zhang AU - Zhengwei Li Y1 - 2019/01/01 UR - http://medrxiv.org/content/early/2019/10/21/19009449.abstract N2 - OBJECTIVES the aim of this meta-analysis was pooled on the comprehensive information of the epidemiology of VZV infection and analyzed the seropositivity of VZV-IgG antibodies in different age groups in China, so as to arouse people’s attention on VZV.DESIGN Systematic reviewDATA SOURCES Sources included on PubMed, the China National Knowledge Infrastructure (CNKI) database, WANFANG database and the Chinese Scientific Journals Full-Text Database (CQVIP) from 1997 to 2019.ELIGIBILITY CRITERIA (1) the Chinese and English literatures of study on varicella-zoster virus immunization epidemics in different regions of China; (2) The literature has obvious age stratification; (3) The subjects are general people; (4) VZV sero-prevalence in the population investigated by the literature research institute. Exclusion criteria: Any study that did not contain these information was excluded.DATA EXTRACTION AND SYNTHESIS Two evaluators independently retrieved documents and extracted data. Information about the study design, eligible population, age and gender distribution, inclusion and exclusion criteria were checked. When they disagreed, they could solve the problem by discussion or by soliciting opinions from third parties.RESULTS Literatures were screened according to the inclusion criteria and 10 studies from 1997 to 2019 with a total of 11666 individuals were included. The overall VZV seroprevalence in the Chinese population was 65.80% (95% CI; 56.5% - 75.1%), and the peak prevalence was seen in the age 36-45 93.50% (95% CI; 0.917-0.953) while the VZV seroprevalence rate (82.20%, 95% CI: 0.544-1.099) was not increased in individuals of 45 and older.CONCLUSION The incidence of VZV increases with age, and there was no significant difference between different genders or regions. This results can provide epidemiological evidence for the prevention and treatment of VZV.Strengths and limitations of this studyA broad search strategy and systematic review methodology were used to generate this comprehensive review on advice for prevention and treatment of VZV.Every inclusion article was assessed with a risk of bias tool and/or a quality assessment tool.Because of relatively small sample size, the incomplete data, and the different research objects, there are some bias in the outcomes, which limits the ability to make discrete conclusions.There were not enough articles identified to perform a meta-analysis.Competing Interest StatementThe authors have declared no competing interest.Funding StatementKey Research & Development Program Projects of Shaanxi Province, China (2015SF080, 2017SF-336, 2019SF-163) and The Medical Project of Xi’an Science and Technology Bureau, China(2017122SF/YX016 (5)).Author DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.Not ApplicableAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Yesnone ER -